“Hematological Adverse Effects in HCV Patients Treated With Pegylated Interferon and Ribavirin in a Tertiary Care Hospital Peshawar”, mfm, vol. 26, no. 3, May 2024, Accessed: Feb. 01, 2026. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/2736